Literature DB >> 25489986

A National Survey of Glaucoma Specialists on the Preoperative (Trabeculectomy) Management of the Ocular Surface (.).

Rajen Tailor1, Ruchika Batra1, Shabbir Mohamed1.   

Abstract

BACKGROUND: Preserved anti-glaucoma drops cause ocular surface disease (OSD), which is increasingly being recognized as a likely cause of trabeculectomy failure. AIM: To determine the routine pre-trabeculectomy management of the ocular surface by glaucoma specialists.
METHODS: A questionnaire consisting of 11 questions was posted to 146 UK glaucoma specialists.
RESULTS: The first-time response rate was 43.8%. Regarding routine pre-operative management, 40.6% of specialists use preservative-free drops, 29.7% commence a drop holiday, and 53% advise lid hygiene. 42.1% prescribe lubricants, 50% prescribe topical steroids, 7.8% topical NSAIDs, and 34.4% systemic tetracyclines. 84.4% of specialists change their routine management if OSD is present. Pre-operative optimization of the ocular surface is viewed "necessary" by 48.4% and "beneficial" by 85.9%.
CONCLUSION: A wide variation exists in the routine pre-operative management of the ocular surface. Research to determine the impact of different pre-operative interventions upon trabeculectomy outcomes is required.

Entities:  

Keywords:  Glaucoma; ocular surface disease; ocular surface inflammation; preservative; trabeculectomy

Mesh:

Substances:

Year:  2014        PMID: 25489986     DOI: 10.3109/08820538.2014.986585

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  4 in total

Review 1.  [Revision after filtration surgery].

Authors:  A G M Jünemann; R Rejdak; B Hohberger
Journal:  Ophthalmologe       Date:  2016-11       Impact factor: 1.059

2.  Understanding practice patterns of glaucoma sub-specialists in India.

Authors:  Nikhil S Choudhari; Vanita Pathak-Ray; Sushmita Kaushik; Prateep Vyas; Ronnie George
Journal:  Int J Ophthalmol       Date:  2017-10-18       Impact factor: 1.779

3.  Topical Steroids and Glaucoma Filtration Surgery Outcomes: An In Vivo Confocal Study of the Conjunctiva.

Authors:  Leonardo Mastropasqua; Lorenza Brescia; Francesca D'Arcangelo; Mario Nubile; Giada D'Onofrio; Michele Totta; Fabiana Perna; Raffaella Aloia; Luca Agnifili
Journal:  J Clin Med       Date:  2022-07-07       Impact factor: 4.964

4.  The ocular surface after successful glaucoma filtration surgery: a clinical, in vivo confocal microscopy, and immune-cytology study.

Authors:  Luca Agnifili; Lorenza Brescia; Francesco Oddone; Matteo Sacchi; Erminia D'Ugo; Guido Di Marzio; Fabiana Perna; Ciro Costagliola; Rodolfo Mastropasqua
Journal:  Sci Rep       Date:  2019-08-05       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.